Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Hugo Fuentes
Pathological Response in a Triple Negative Breast Cancer Cohort Treated With Neoadjuvant Carboplatin and Docetaxel According to Lehmann's Refined Classification
Clinical Cancer Research
Cancer Research
Oncology
Related publications
A microRNA Signature Associated With Pathological Complete Response to Novel Neoadjuvant Therapy Regimen in Triple-Negative Breast Cancer
Tumor Biology
Medicine
Cancer Research
Cisplatin Versus Carboplatin in Combination With Paclitaxel as Neoadjuvant Regimen for Triple Negative Breast Cancer
OncoTargets and Therapy
Oncology
Pharmacology
PIK3CA H1047R Mutation Associated With a Lower Pathological Complete Response Rate in Triple-Negative Breast Cancer Patients Treated With Anthracycline-Taxane–Based Neoadjuvant Chemotherapy
Cancer Research and Treatment
Cancer Research
Oncology
CD44v9 as a Poor Prognostic Factor of Triple-Negative Breast Cancer Treated With Neoadjuvant Chemotherapy
Breast Cancer
Nuclear Medicine
Radiology
Pharmacology
Oncology
Imaging
Medicine
Comedications Influence Immune Infiltration and Pathological Response to Neoadjuvant Chemotherapy in Breast Cancer
OncoImmunology
Oncology
Allergy
Immunology
Association of Pretreatment Anemia With Pathological Response and Survival of Breast Cancer Patients Treated With Neoadjuvant Chemotherapy: A Population-Based Study
PLoS ONE
Multidisciplinary
[18f]ml-10 PET Imaging Fails to Assess Early Response to Neoadjuvant Chemotherapy in a Preclinical Model of Triple Negative Breast Cancer
EJNMMI Research
Nuclear Medicine
Radiology
Imaging
Targeted-Gene Sequencing to Catch Triple Negative Breast Cancer Heterogeneity Before and After Neoadjuvant Chemotherapy
Cancers
Cancer Research
Oncology
Triple-Negative Breast Cancer
